These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31157270)

  • 21. Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study.
    Hoesly PM; Lowe GC; Lohse CM; Brewer JD; Lehman JS
    J Am Acad Dermatol; 2015 Mar; 72(3):419-25. PubMed ID: 25582537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
    Abbott JJ; Oliveira AM; Nascimento AG
    Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic dermatofibrosarcoma protuberans with fibrosarcomatous change in the absence of local recurrence. A case report of simultaneous occurrence with a malignant giant cell tumor of soft parts.
    Eisen RN; Tallini G
    Cancer; 1993 Jul; 72(2):462-8. PubMed ID: 8319177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).
    Stacchiotti S; Pantaleo MA; Negri T; Astolfi A; Tazzari M; Dagrada GP; Urbini M; Indio V; Maestro R; Gronchi A; Fiore M; Dei Tos AP; Conca E; Palassini E; Vincenzi B; Grosso F; Pilotti S; Castelli C; Casali PG
    Clin Cancer Res; 2016 Feb; 22(4):837-46. PubMed ID: 26261104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Osaki J; Ono T; Adachi Y; Tsuchiya R; Toda Y; Ogura K; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2023 Nov; 36(6):2187-2194. PubMed ID: 37490236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution.
    Jing C; Zhang H; Zhang X; Yu S
    Dermatol Surg; 2021 Feb; 47(2):e26-e30. PubMed ID: 32769521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
    Arican O; Bakaris S; Bulbuloglu E; Ezberci F
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An uncommon malignancy of the breast: dermatofibrosarcoma protuberans with fibrosarcomatous transformation (DFSP-FS)].
    Ledniczky G; Bognár G; Diczházi C; Bereczky B; Barabás L; Ondrejka P
    Magy Seb; 2009 Feb; 62(1):27-9. PubMed ID: 19218166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
    Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
    Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Risk Factors for Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans.
    Mallett KE; Almubarak S; Claxton RM; Ferguson PC; Griffin AM; Rose PS; Wunder JS; Tsoi K; Houdek MT
    Anticancer Res; 2022 Jan; 42(1):105-108. PubMed ID: 34969715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hiraki-Hotokebuchi Y; Yamada Y; Kohashi K; Yamamoto H; Endo M; Setsu N; Yuki K; Ito T; Iwamoto Y; Furue M; Oda Y
    Hum Pathol; 2017 Sep; 67():60-68. PubMed ID: 28711648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans.
    Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Oda S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2004 Feb; 35(2):240-5. PubMed ID: 14991543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
    Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
    Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: a case report.
    Hrudka J; Charvát M; Grossmann P; Kinkor Z
    Cesk Patol; 2020; 56(2):89-93. PubMed ID: 32493025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rare Lower Extremity Fibrosarcomatous Variant of Dermatofibrosarcoma With Myxoid Features Treated With Transtibial Amputation.
    Pryor EK; Sinkler MA; Ullah A; Martin E; Homlar K
    Cureus; 2021 Sep; 13(9):e18079. PubMed ID: 34692297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatofibrosarcoma Protuberans of the Vulva With Myoid Differentiation.
    Bernárdez C; Machan S; Molina-Ruiz AM; Pérez de la Fuente T; Pavón M; Carrillo I; Fortes J; Requena L
    Am J Dermatopathol; 2015 Sep; 37(9):e107-11. PubMed ID: 25943241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.
    Stacchiotti S; Astolfi A; Gronchi A; Fontana A; Pantaleo MA; Negri T; Brenca M; Tazzari M; Urbini M; Indio V; Colombo C; Radaelli S; Brich S; Dei Tos AP; Casali PG; Castelli C; Dagrada GP; Pilotti S; Maestro R
    Mol Cancer Res; 2016 Sep; 14(9):820-9. PubMed ID: 27256159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.
    Saeki H; Hoashi T; Tada Y; Ashida R; Kuwano Y; Le Pavoux A; Tsunemi Y; Shikada J; Torii H; Kawabata Y; Kikuchi K; Tamada Y; Matsumoto Y; Tamaki K
    J Dermatol Sci; 2003 Dec; 33(3):161-7. PubMed ID: 14643521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans of the Male Breast and its Association with Magnetic Resonance Imaging and Immunohistopathologic Features.
    Kang SY; Choi EJ; Jang KY
    Curr Med Imaging; 2024; 20():e15734056309290. PubMed ID: 38757329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.